Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Aberrant Active cis-Regulatory Elements Associated with Downregulation of RET Finger Protein Overcome Chemoresistance in Glioblastoma.

Ranjit M, Hirano M, Aoki K, Okuno Y, Ohka F, Yamamichi A, Kato A, Maeda S, Motomura K, Matsuo K, Enomoto A, Ino Y, Todo T, Takahashi M, Wakabayashi T, Kato T, Natsume A.

Cell Rep. 2019 Feb 26;26(9):2274-2281.e5. doi: 10.1016/j.celrep.2019.01.109.

2.

Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells.

Zhou B, Bu G, Zhou Y, Zhao Y, Li W, Li M.

Med Oncol. 2015 Jan;32(1):378. doi: 10.1007/s12032-014-0378-9. Epub 2014 Nov 30.

PMID:
25433945
3.

Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer.

Horio M, Kato T, Mii S, Enomoto A, Asai M, Asai N, Murakumo Y, Shibata K, Kikkawa F, Takahashi M.

Cancer Med. 2012 Oct;1(2):218-29. doi: 10.1002/cam4.32. Epub 2012 Sep 13.

4.

Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity.

Zhang D, Dai D, Zhou M, Li Z, Wang C, Lu Y, Li Y, Wang J.

Cell Physiol Biochem. 2018;51(6):2496-2508. doi: 10.1159/000495920. Epub 2018 Dec 11.

5.

Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.

Hanihara M, Kawataki T, Oh-Oka K, Mitsuka K, Nakao A, Kinouchi H.

J Neurosurg. 2016 Jun;124(6):1594-601. doi: 10.3171/2015.5.JNS141901. Epub 2015 Dec 4.

PMID:
26636389
6.

A RING finger motif regulates transforming activity of the rfp/ret fusion gene.

Hasegawa N, Iwashita T, Asai N, Murakami H, Iwata Y, Isomura T, Goto H, Hayakawa T, Takahashi M.

Biochem Biophys Res Commun. 1996 Aug 14;225(2):627-31.

PMID:
8753810
7.

FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.

Lin J, Ji A, Qiu G, Feng H, Li J, Li S, Zou Y, Cui Y, Song C, He H, Lu Y.

Cancer Sci. 2018 Apr;109(4):1001-1011. doi: 10.1111/cas.13528.

8.

Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.

Wang Q, Qian J, Wang J, Luo C, Chen J, Hu G, Lu Y.

J Neurooncol. 2013 Mar;112(1):73-82. doi: 10.1007/s11060-013-1045-2. Epub 2013 Jan 6.

PMID:
23292182
9.

Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.

Polewski MD, Reveron-Thornton RF, Cherryholmes GA, Marinov GK, Cassady K, Aboody KS.

Mol Cancer Res. 2016 Dec;14(12):1229-1242. Epub 2016 Sep 22.

10.

miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.

Wang J, Sai K, Chen FR, Chen ZP.

Cancer Chemother Pharmacol. 2013 Jul;72(1):147-58. doi: 10.1007/s00280-013-2180-3. Epub 2013 May 5.

PMID:
23645289
11.

Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51.

Xipell E, Aragón T, Martínez-Velez N, Vera B, Idoate MA, Martínez-Irujo JJ, Garzón AG, Gonzalez-Huarriz M, Acanda AM, Jones C, Lang FF, Fueyo J, Gomez-Manzano C, Alonso MM.

Neuro Oncol. 2016 Aug;18(8):1109-19. doi: 10.1093/neuonc/now022. Epub 2016 Mar 6.

12.

The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.

Pyrko P, Schönthal AH, Hofman FM, Chen TC, Lee AS.

Cancer Res. 2007 Oct 15;67(20):9809-16.

13.

Downregulation of Id2 increases chemosensitivity of glioma.

Zhao Z, He H, Wang C, Tao B, Zhou H, Dong Y, Xiang J, Wang L, Luo C, Lu Y, Yu X.

Tumour Biol. 2015 Jun;36(6):4189-96. doi: 10.1007/s13277-015-3055-5. Epub 2015 Mar 14.

PMID:
25773386
14.

AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo.

Cui Y, Lin J, Zuo J, Zhang L, Dong Y, Hu G, Luo C, Chen J, Lu Y.

Onco Targets Ther. 2015 Jul 8;8:1681-90. doi: 10.2147/OTT.S83795. eCollection 2015.

15.

The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.

Banelli B, Carra E, Barbieri F, Würth R, Parodi F, Pattarozzi A, Carosio R, Forlani A, Allemanni G, Marubbi D, Florio T, Daga A, Romani M.

Cell Cycle. 2015;14(21):3418-29. doi: 10.1080/15384101.2015.1090063.

16.

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.

Yin D, Ong JM, Hu J, Desmond JC, Kawamata N, Konda BM, Black KL, Koeffler HP.

Clin Cancer Res. 2007 Feb 1;13(3):1045-52.

17.

The Ret finger protein induces apoptosis via its RING finger-B box-coiled-coil motif.

Dho SH, Kwon KS.

J Biol Chem. 2003 Aug 22;278(34):31902-8. Epub 2003 Jun 13.

18.

Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells.

Wu L, Yang L, Xiong Y, Guo H, Shen X, Cheng Z, Zhang Y, Gao Z, Zhu X.

Tumour Biol. 2014 Dec;35(12):12327-37. doi: 10.1007/s13277-014-2545-1. Epub 2014 Sep 23.

PMID:
25245332
19.

Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.

Aghi M, Rabkin S, Martuza RL.

J Natl Cancer Inst. 2006 Jan 4;98(1):38-50.

PMID:
16391370
20.

miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.

Li S, Zeng A, Hu Q, Yan W, Liu Y, You Y.

Neuro Oncol. 2017 Jan;19(1):55-65. doi: 10.1093/neuonc/now129. Epub 2016 Jul 28.

Supplemental Content

Support Center